Abstract

BackgroundPolysulfone (PS) dialyzers are most frequently used worldwide for chronic renal failure patients and they are produced by several manufacturers. Despite using the same materials, differences in biocompatibility among PS dialyzers have been reported. TORAYLIGHT NV (NV) is a PS dialyzer that was reported to have superior biocompatibility compared with other PS membranes (conventional PS membranes). Therefore, we examined whether biocompatibility of PS membranes would affect the occurrence of cardiovascular events in hemodialysis patients with diabetic nephropathy (DN).MethodsFifty hemodialysis patients with DN were enrolled. They were randomly divided into NV and PS groups and then followed up for 3 years. The number of patients who developed cardiovascular events and clinical data including laboratory tests and blood pressure was recorded.ResultsThere were 13 and 14 patients who developed cardiovascular events during the 3-year follow-up of the NV and PS groups, respectively. There was no significant difference between the groups. There were no significant differences in most of the clinical data between the two groups. However, serum pentosidine concentrations in the PS group significantly increased throughout this study, while those in the NV group did not change. Additionally, the width of the systolic blood pressure drop, which was shown to be the difference between before and after dialysis session, in the PS group showed no change, while that in the NV group tended to decrease.ConclusionsThe superiority of using NV membrane compared with conventional PS membranes in reducing cardiovascular events in hemodialysis patients with DN remains unclear. However, our results suggested that PS membranes with superior biocompatibility would slow the progression of atherosclerosis and reduce the occurrence of intradialytic hypotension.Trial registrationThis study was retrospectively registered with the Clinical Trials Registry at the University Hospital Medical Information Network (UMIN-CTR) on March 17, 2017 (registration ID, UMIN 000026339). https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&recptno=R000030259&type=summary&language=J

Highlights

  • Polysulfone (PS) dialyzers are most frequently used worldwide for chronic renal failure patients and they are produced by several manufacturers

  • Despite using the same material, differences in biocompatibility among PS dialyzers have been reported [1, 2]. It is well-known that the conditions of the inner surface of the hollow fiber membrane are related to the biocompatibility of hemodialyzers because blood cells including white blood cells (WBCs), red blood cells, and platelets (PLTs) contact the hollow fiber membrane

  • There are some reports of low PLT activation [2, 4, 5], which possibly reduces the occurrence of intradialytic hypotension (IDH) [6] and the dose of erythrocyte stimulating agents (ESAs) [7, 8] in NV compared with other PS dialyzers

Read more

Summary

Introduction

Polysulfone (PS) dialyzers are most frequently used worldwide for chronic renal failure patients and they are produced by several manufacturers. Many patients with chronic renal failure (CRF) undergo hemodialysis using hollow fiber-type dialyzers. Polysulfone (PS) dialyzers are most frequently used for CRF patients worldwide, and they are produced by several manufacturers. Despite using the same material, differences in biocompatibility among PS dialyzers have been reported [1, 2]. It is well-known that the conditions of the inner surface of the hollow fiber membrane are related to the biocompatibility of hemodialyzers because blood cells including white blood cells (WBCs), red blood cells, and platelets (PLTs) contact the hollow fiber membrane. There are some reports of low PLT activation [2, 4, 5], which possibly reduces the occurrence of intradialytic hypotension (IDH) [6] and the dose of erythrocyte stimulating agents (ESAs) [7, 8] in NV compared with other PS dialyzers (conventional PS dialyzers)

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.